» Articles » PMID: 25977381

β-Glucan from Saccharomyces Cerevisiae Induces IFN-γ Production In Vivo in BALB/c Mice

Overview
Journal In Vivo
Specialty Oncology
Date 2015 May 16
PMID 25977381
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: β-Glucan is one of the most abundant polymers in nature and has been established as an immunomodulator. This compound has notable physiological effects on mammalian immune systems, including anti-tumor and anti-infective activities and can activate the immune response. It is considered that the immune-stimulating activities of β-glucan can depend on physicochemical parameters, such as molecular size. Saccharomyces cerevisiae, also known as baker's yeast, is a frequently used source of β-glucan. The aim of the experiments was to investigate how different Saccharomyces cerevisiae β-glucan preparations with different molecular size affect interferon-gamma (IFN-γ) production in BALB/c mice.

Materials And Methods: In vivo and in vitro BALB/c mouse models were used for the investigations. Different β-glucan preparations were orally administrated in the in vivo experiments. IFN-γ production in BALB/c mice was analyzed by enzyme-linked immunosorbent assay and measuring interferon-γ RNA concentration.

Results: The results showed that orally-administered β-glucan from S. cerevisiae enhanced IFN-γ production in BALB/c mice in the in vivo model, but not by mouse leukocytes in vitro. Moreover, water-soluble β-glucan enhanced IFN-γ production more effectively than did particulate β-glucan.

Conclusion: IFN-γ plays an important role in immunity against viral and bacterial infections. Our experiments have shown that β-glucan preparations enhance IFN-γ production in BALB/c mice and can be potentially used for immune system stimulation in mammals. Current results may be used to develop soluble β-glucan nutritional supplements.

Citing Articles

β-glucan: a potent adjuvant in immunotherapy for digestive tract tumors.

Wang M, Pan J, Xiang W, You Z, Zhang Y, Wang J Front Immunol. 2024; 15:1424261.

PMID: 39100668 PMC: 11294916. DOI: 10.3389/fimmu.2024.1424261.


Potential promising anticancer applications of β-glucans: a review.

Noorbakhsh Varnosfaderani S, Ebrahimzadeh F, Akbari Oryani M, Khalili S, Almasi F, Mosaddeghi Heris R Biosci Rep. 2023; 44(1).

PMID: 38088444 PMC: 10776902. DOI: 10.1042/BSR20231686.


Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery.

Mazzio E, Barnes A, Badisa R, Council S, Soliman K Front Oncol. 2023; 13:1180084.

PMID: 37588095 PMC: 10426289. DOI: 10.3389/fonc.2023.1180084.


In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice.

Park H, Lee S, Park Y, Kim T, Lee S, Lee S Molecules. 2023; 28(15).

PMID: 37570749 PMC: 10421142. DOI: 10.3390/molecules28155779.


Probiotic potential of Saccharomyces cerevisiae GILA with alleviating intestinal inflammation in a dextran sulfate sodium induced colitis mouse model.

Kil B, Pyung Y, Park H, Kang J, Yun C, Huh C Sci Rep. 2023; 13(1):6687.

PMID: 37095161 PMC: 10125971. DOI: 10.1038/s41598-023-33958-7.